Contribution of bacterial cell wall compounds to airway hyperreactivity.
D000818:Animals; D001249:Asthma / Q000378:metabolism / Q000517:prevention & control; D001428:Bacterial Vaccines / Q000627:therapeutic use; D001886:Bordetella pertussis / Q000276:immunology; D004082:Dihydroalprenolol / Q000378:metabolism; D004926:Escherichia coli / Q000145:classification / Q000276:immunology; D006168:Guinea Pigs; D006193:Haemophilus influenzae / Q000276:immunology*; D008168:Lung / Q000276:immunology; D011135:Polysaccharides, Bacterial / Q000276:immunology; D011943:Receptors, Adrenergic, beta / Q000032:analysis / Q000276:immunology* / Q000378:metabolism; D013296:Streptococcus pneumoniae / Q000276:immunology; D014316:Tritium
D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial; D011943:Receptors, Adrenergic, beta; D014316:Tritium; D004082:Dihydroalprenolol